InsiderTrades

Chanda Sanjay

SEC CIK 1571820 · EDGAR

Buying vs selling by month open-market trades, last 24 months, ANTX
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ANTXAN2 Therapeutics, Inc.Chief Development Off 118.8K — $13.3K 62024-03-152026-02-20

Most active insiders at ANTX, 12 months

#InsiderTitleBoughtSold
1 Readnour Robin ShaneDir —$316.7K
2 Eizen Joshua MSee Remarks —$52.9K
3 FitzPatrick Margaret MDir $11.6K—
4 Chanda SanjayChief Development Off —$9,311
5 Day LucyCFO —$8,862
6 Prior Stephen DavidChief Strategy Off —$7,363
7 Williams Sarah JoannePrincipal Accounting Off —$3,025
8 Trenor Cameron C. IIIChief Medical Off ——
9 Marks Gilbert LynnDir ——
10 Martin Patricia A.Dir ——

Transactions 6

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-23 2026-02-20 ANTX AN2 Therapeutics, Inc. Chanda Sanjay Chief Development Off A - Grant $0.00 +38.0K 118.8K +47% $0
M 2026-01-07 2026-01-05+ ANTX AN2 Therapeutics, Inc. Chanda Sanjay Chief Development Off S - Sale $1.01 -9,251 75.8K -11% -$9,311
D 2025-02-28 2025-02-26 ANTX AN2 Therapeutics, Inc. Chanda Sanjay Chief Development Off A - Grant $0.00 +50.2K 80.1K +168% $0
2025-01-07 2025-01-03 ANTX AN2 Therapeutics, Inc. Chanda Sanjay Chief Development Off S - Sale $1.34 -2,957 29.8K -9% -$3,962
A 2024-03-29 2024-03-15 ANTX AN2 Therapeutics, Inc. Chanda Sanjay Chief Development Off A - Grant $0.00 +27.5K 28.2K +3,741% $0
D 2024-03-18 2024-03-15 ANTX AN2 Therapeutics, Inc. Chanda Sanjay Chief Development Off A - Grant $0.00 +27.5K 28.2K +3,741% $0

Purchase Sale Sale after option exercise All abbreviations